RxDoctor Payments Data

Shae Paschal, DPM

Foot & Ankle Surgery · Arlington, TXNPI 1942431341

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 99.8% of the total across 58 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 22 manufacturers reported payments, led by Stryker at 24.1% of the total. Reporting peaked in 2019 at $805 and has fallen 79.4% since, to $166 in 2025. That places this record below the midpoint for foot & ankle surgery clinicians in TX, where the typical reported total is $3,901.

$2,024in general payments, 2019–2025

Across 58 payments — averaging $34.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$487
  • Bone Support Inc.$292
  • Smith+Nephew$207
  • Melinta Therapeutics, LLC$137
  • Integra Lifesciences Corporation$120
  • Fusion Orthopedics USA, LLC$109
  • plus $672 from 16 others

What the payments were for

  • Travel & lodging$40%
  • Food & beverage$2,020100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,024 in reported general payments places this provider in the 30th percentile of 684 foot & ankle surgery providers in Texas.

See all foot & ankle surgery providers in Texas →

Medicare billing

Part B allowed, 2024
$150,500
Medicare patients
334
Services billed
2,342

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ciclopirox50$2,063
Doxycycline Monohydrate32$563
Ketoconazole30$555
Clindamycin Hcl73$462
Gabapentin17$333
Methylprednisolone21$153
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen18$147
Cephalexin23$103

Paid to pharmacies, not to this prescriber.

Other foot & ankle surgery in Arlington

See the full list for Texas →

Where these figures come from

Is this you, or does something look wrong? →